Skip to main content
. 2021 Jun 21;16:1173–1184. doi: 10.2147/CIA.S306255

Table 3.

Median (IQR) Secondary Outcomes Scores for Each Group, and Results of GEE Analysis (PP Analysis, n = 200; Experimental Group n = 105, Control Group n = 95)

Outcome Measure Baseline (t0) 7 Days (t1) 4 Weeks (t2) 12 Weeks (t3) Treatment ˄ Time Effect ˄ Treatment× Time Effect ˄
Experimental Group Control Group Experimental Group Control Group Experimental Group Control Group Experimental Group Control Group Wald Chi-Square P value Wald Chi-Square P value Wald Chi-Square P value
MBI 31.00 (20.00–50.00) 28.00 (20.00 −56.00) 52.00 (25.50 −77.50) 39.00 (23.00 −68.00) 75.00 (51.50–97.00) 68.00 (42.00 −87.00) 90.00 (71.50 −100.00) 81.00 (60.00 −98.00) 1.362 0.243 945.421 <0.001* 16.319 0.001*
NIHSS 6.00 (4.00 −9.00) 6.00 (3.00 −10.00) 5.00 (2.00–6.50) 4.00 (2.00–9.00) 2.00 (0.00–4.00) 2.00 (1.00 −4.00) 0.00 (0.00 −1.00) 1.00 (0.00 −2.00) 0.421 0.516 507.837 <0.001* 6.732 0.081
mRS 4.00 (4.00 −4.00) 4.00 (4.00 −4.00) 4.00 (3.00–4.00) 4.00 (3.00–4.00) 3.00 (3.00–4.00) 3.00 (3.00 −4.00) 2.00 (1.00–3.00) 3.00 (2.00 −3.00) 0.716 0.397 272.803 <0.001* 5.176 0.159

Notes: ˄Results of Generalized estimating equation (GEE) analysis for group by time effect across all timepoints; *P < 0.05/3 = 0.0167.

Abbreviations: IQR, interquartile range; MBI, modified Barthel index; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale.